Matrix Laboratories Ltd http://www.alacrastore.com/company-snapshot/Matrix_Laboratories_Ltd-2519344 27 Nov 2009 12:13:01 EST 2519344 Matrix Laboratories Ltd en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/bir/13229391322939bir/1322939norm9Matrix Laboratories Ltd.India29 Oct 2009 07:25:00 ESTManufacturing: Research, development, manufacture and distribution of active pharmaceutical ingredients (APIs) and solid oral dosage forms. Matrix is one of the fastest-growing API manufacturers in India and focuses on regulated markets such as the USA anBOMBAY325412H2834F42421054171051228731524794Manufacturing: Research, development, manufacture and distribution of active pharmaceutical ingredients (APIs) and solid oral dosage forms. Matrix is one of the fastest-growing API manufacturers in India and focuses on regulated markets such as the USA anCompany Profiles & FinancialsGale Company ProfilesINDIA - MP Laboratories (Mauritius) Ltd of Mauritius, a wholly-owned unit of Mylan Inc of the US, planned to a lunch a tender to raise its interest to ##.##% from ##. ##%, by acquiring a ##.##% stake, or ##.## mil ordinary shares in Matrix Laboratories Ltd (ML), a Secunderabad- based manufacturer of prescription pharmaceuticals, for ### Indian rupees ($#.## US) in cash per share, or a total value of #.### bil Indian rupees ($###.### mil US). Upon completion, ML was to be delisted from the Bombay Stock Exchange. The transaction was subject to board of directors? approval.28 Mar 2009 07:49:43 EST55191Y57695X628530628530MP Laboratories(Mauritius)LtdMatrix Laboratories LtdMylan IncMylan Inchttp://www.alacrastore.com/storecontent/Thomson_M%26A/MP_Laboratories_Mauritius_Ltd_intends_to_acquire_a_minority_stake_in_Matrix_Laboratories_Ltd_from_Mylan_Laboratories_Inc-2061283040sdc/20612830402061283040Copyright © 2009, Thomson Financial, All Rights ReservedDrugsMauritiusPharmaceutical preparations2834FFForeignSubsidiary2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances2834:Pharmaceutical preparations3841:Surgical and medical instruments and apparatus8731:Commercial physical and biological researchBombayDrugsIndiaPharmaceutical preparations2834FFForeignPublic52479454883001Mnfr,whl pharmMnfr,whl pharmCashCash OnlyOrdinary Share349093003Mar 28 20090.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.00000MP Laboratories (Mauritius)Ltd, located in Mauritius,manufactures pharmaceuticals.MP Laboratories (Mauritius) Ltd, located in Mauritius,manufactures pharmaceuticals.MP Laboratories (Mauritius) Ltd, located in Mauritius, manufactures pharmaceuticals.1.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.0000014.00000Matrix Laboratories Ltd,located in Secunderabad,Indian, manufacturesprescription pharmaceuticalsintended for finalconsumption, including biotechproducts and antibiotics;manufacture activepharmaceutical ingredients andsolid oral dosage forms. Thecompany also provides researchand development services. Thecompany was founded in 29November 2009.Matrix Laboratories Ltd, located in Secunderabad, Indian,manufactures prescription pharmaceuticals intended for finalconsumption, including biotech products and antibiotics;manufacture active pharmaceutical ingredients and solid oraldosage forms. The company also provides research anddevelopment services. The company was founded in 29 November2009.Matrix Laboratories Ltd, located in Secunderabad, Indian, manufactures prescription pharmaceuticals intended for final consumption, including biotech products and antibiotics; manufacture active pharmaceutical ingredients and solid oral dosage forms. The company also provides research and development services. The company was founded in 29 November 2009.0.000000.000000.00000154.61000YIndian Rupee26 Mar 09Thu, 26 Mar 2009 00:00:00 ESTDate Announced: 03/26/2009Date Effective:Acq. Part. Int.Friendly0.000000.000000.000000.000000.00000150.00000Price/Share0.000005536.53 Indian Rupee5536.5280023191.896005536.53 Indian Rupee5536.528000.000000.000002.980002.980005536.528005536.53 Indian Rupee0.02000N76.099000.000000.000000.000000.000000.00000109.97800109.978000.000000.000000.000000.000000.000000.000000.0000071.1610023.873000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.0000014.0000015.0000016.0000017.0000018.0000019.0000020.0000021.00000INDIA - MP Laboratories(Mauritius) Ltd of Mauritius,a wholly-owned unit of MylanInc of the US, planned to alunch a tender to raise itsinterest to 95.03% from 71.16%, by acquiring a 23.87%stake, or 36.91 mil ordinaryshares in Matrix LaboratoriesLtd (ML), a Secunderabad-based manufacturer ofprescription pharmaceuticals,for 150 Indian rupees ($2.98US) in cash per share, or atotal value of 5.537 bilIndian rupees ($109.978 milUS). Upon completion, ML wasto be delisted from theBombay Stock Exchange. Thetransaction was subject toboard of directors? approval.INDIA - MP Laboratories (Mauritius) Ltd of Mauritius, a wholly-owned unit of Mylan Inc of the US, planned to a lunch a tender to raise its interest to 95.03% from 71. 16%, by acquiring a 23.87% stake, or 36.91 mil ordinary shares in Matrix Laboratories Ltd (ML), a Secunderabad- based manufacturer of prescription pharmaceuticals, for 150 Indian rupees ($2.98 US) in cash per share, or a total value of 5.537 bil Indian rupees ($109.978 mil US). Upon completion, ML was to be delisted from the Bombay Stock Exchange. The transaction was subject to board of directors? approval.INDIA - MP Laboratories (Mauritius) Ltd of Mauritius, a wholly-owned unit of Mylan Inc ofthe US, planned to a lunch a tender to raise its interest to 95.03% from 71. 16%, byacquiring a 23.87% stake, or 36.91 mil ordinary shares in Matrix Laboratories Ltd (ML), aSecunderabad- based manufacturer of prescription pharmaceuticals, for 150 Indian rupees($2.98 US) in cash per share, or a total value of 5.537 bil Indian rupees ($109.978 milUS). Upon completion, ML was to be delisted from the Bombay Stock Exchange. Thetransaction was subject to board of directors? approval.INDIA - MP Laboratories (Mauritius) Ltd of Mauritius, a wholly-owned unit of Mylan Inc of the US, planned to a lunch a tender to raise its interest to 95.03% from 71. 16%, by acquiring a 23.87% stake,or 36.91 mil ordinary shares in Matrix Laboratories Ltd (ML), a Secunderabad- based manufacturer of prescription pharmaceuticals, for 150 Indian rupees ($2.98 US) in cash per share, or a total valueof 5.537 bil Indian rupees ($109.978 mil US). Upon completion, ML was to be delisted from the Bombay Stock Exchange. The transaction was subject to board of directors? approval.INDIA - MP Laboratories (Mauritius) Ltd of Mauritius, a wholly-owned unit of Mylan Inc of the US, planned to a lunch a tender to raiseits interest to 95.03% from 71. 16%, by acquiring a 23.87% stake, or 36.91 mil ordinary shares in Matrix Laboratories Ltd (ML), aSecunderabad- based manufacturer of prescription pharmaceuticals, for 150 Indian rupees ($2.98 US) in cash per share, or a total value of5.537 bil Indian rupees ($109.978 mil US). Upon completion, ML was to be delisted from the Bombay Stock Exchange. The transaction wassubject to board of directors? approval.Intended0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000Status:Intended-999.00000np0.00000-999.00000np0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000002833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances8731:Commercial physical and biological research30972003NasdaqUnited States2834PennsylvaniaPublicMYL2834:Pharmaceutical preparations3841:Surgical and medical instruments and apparatus8731:Commercial physical and biological research30972003NasdaqUnited States2834PennsylvaniaPublicMYL109.978005536.52800109.9780076.09900Deal InformationTF Mergers & Acquisitions